A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff
Clinical trial NCT04497987 · COMPLETED
Trial details
- NCT number
- NCT04497987
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-02
- Primary completion
- 2021-01-16
- Enrollment
- 1180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.